Free Trial

Octopus AIM VCT 2 (OSEC) Competitors

GBX 38.80 0.00 (0.00%)
(As of 12/24/2024 ET)

OSEC vs. BIOG, HHI, NCYF, BOOK, GSEO, RECI, GRID, MTE, BRK, and IBT

Should you be buying Octopus AIM VCT 2 stock or one of its competitors? The main competitors of Octopus AIM VCT 2 include The Biotech Growth Trust (BIOG), Henderson High Income Trust (HHI), CQS New City High Yield (NCYF), Literacy Capital (BOOK), VH Global Sustainable Energy Opportunities (GSEO), Real Estate Credit Investments (RECI), Gresham House Energy Storage (GRID), Montanaro European Smaller (MTE), Brooks Macdonald Group (BRK), and International Biotechnology (IBT). These companies are all part of the "asset management" industry.

Octopus AIM VCT 2 vs.

The Biotech Growth Trust (LON:BIOG) and Octopus AIM VCT 2 (LON:OSEC) are both small-cap financial services companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, community ranking, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings.

The Biotech Growth Trust has a net margin of 92.85% compared to Octopus AIM VCT 2's net margin of 0.00%. The Biotech Growth Trust's return on equity of 21.57% beat Octopus AIM VCT 2's return on equity.

Company Net Margins Return on Equity Return on Assets
The Biotech Growth Trust92.85% 21.57% 12.39%
Octopus AIM VCT 2 N/A -16.85%-10.46%

The Biotech Growth Trust received 50 more outperform votes than Octopus AIM VCT 2 when rated by MarketBeat users. However, 72.73% of users gave Octopus AIM VCT 2 an outperform vote while only 64.06% of users gave The Biotech Growth Trust an outperform vote.

CompanyUnderperformOutperform
The Biotech Growth TrustOutperform Votes
82
64.06%
Underperform Votes
46
35.94%
Octopus AIM VCT 2Outperform Votes
32
72.73%
Underperform Votes
12
27.27%

The Biotech Growth Trust has a beta of 0.5, indicating that its stock price is 50% less volatile than the S&P 500. Comparatively, Octopus AIM VCT 2 has a beta of 0.55, indicating that its stock price is 45% less volatile than the S&P 500.

28.6% of The Biotech Growth Trust shares are owned by institutional investors. 0.7% of The Biotech Growth Trust shares are owned by company insiders. Comparatively, 0.3% of Octopus AIM VCT 2 shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

The Biotech Growth Trust has higher revenue and earnings than Octopus AIM VCT 2. Octopus AIM VCT 2 is trading at a lower price-to-earnings ratio than The Biotech Growth Trust, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Biotech Growth Trust£80.35M3.44£74.60M£2.07415.46
Octopus AIM VCT 2-£13.61M-5.23-£15.71M-£0.10-388.00

In the previous week, The Biotech Growth Trust's average media sentiment score of 1.96 beat Octopus AIM VCT 2's score of 0.00 indicating that The Biotech Growth Trust is being referred to more favorably in the media.

Company Overall Sentiment
The Biotech Growth Trust Very Positive
Octopus AIM VCT 2 Neutral

Summary

The Biotech Growth Trust beats Octopus AIM VCT 2 on 12 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OSEC vs. The Competition

MetricOctopus AIM VCT 2Asset Management IndustryFinancial SectorLON Exchange
Market Cap£71.19M£1.08B£3.72B£1.94B
Dividend Yield7.44%4.65%4.43%5.26%
P/E Ratio-388.00803.84419.421,918.43
Price / Sales-5.231,469.481,749.81416,255.30
Price / Cash3.3364.8552.4929.14
Price / Book0.811.151.932.97
Net Income-£15.71M£63.69M£434.96M£183.11M
7 Day PerformanceN/A0.43%1.68%0.70%
1 Month PerformanceN/A-0.38%1.63%28.85%
1 Year PerformanceN/A6.85%9.60%154.64%

Octopus AIM VCT 2 Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OSEC
Octopus AIM VCT 2
N/AGBX 38.80
flat
N/AN/A£71.19M£-13,610,000.00-388.00N/A
BIOG
The Biotech Growth Trust
N/AGBX 876
+0.2%
N/A+3.0%£281.46M£80.35M418.36N/A
HHI
Henderson High Income Trust
N/AGBX 163
-0.9%
N/A+4.5%£280.59M£38.61M708.70N/APositive News
NCYF
CQS New City High Yield
N/AGBX 51.60
-0.6%
N/A+2.8%£279.85M£23.34M1,720.00N/ANews Coverage
BOOK
Literacy Capital
N/AGBX 464
+2.7%
N/A-5.1%£279.19M£29.26M1,329.416Gap Up
GSEO
VH Global Sustainable Energy Opportunities
N/AGBX 67.40
-1.2%
N/A-17.1%£278.48M£21.90M3,170.00N/APositive News
RECI
Real Estate Credit Investments
N/AGBX 123
-0.4%
N/A-2.0%£272.93M£31.10M1,230.00N/APositive News
GRID
Gresham House Energy Storage
N/AGBX 47.10
+0.5%
N/A-56.9%£268.03M£-100,100,000.00-235.43N/APositive News
MTE
Montanaro European Smaller
N/AGBX 141
-0.4%
N/A+5.2%£267.10M£18.23M1,762.50N/A
BRK
Brooks Macdonald Group
3.1928 of 5 stars
GBX 1,645
+0.9%
GBX 2,150
+30.7%
-13.6%£264.02M£128.26M4,217.95512Gap Up
IBT
International Biotechnology
N/AGBX 698
-2.1%
N/A+11.8%£257.98M£24.14M1,454.17N/APositive News

Related Companies and Tools


This page (LON:OSEC) was last updated on 12/27/2024 by MarketBeat.com Staff
From Our Partners